Sean McCutcheon
Stock Analyst at Raymond James
(1.72)
# 3,370
Out of 5,036 analysts
11
Total ratings
54.55%
Success rate
-3.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $54.01 | +40.71% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $6.27 | +91.39% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $26.91 | +141.55% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $4.05 | +122.22% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $4.11 | +167.64% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $9.33 | +146.52% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $15.07 | +165.43% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $59.35 | +17.94% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $32.91 | +161.32% | 1 | Mar 13, 2024 |
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $54.01
Upside: +40.71%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $6.27
Upside: +91.39%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $26.91
Upside: +141.55%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $4.05
Upside: +122.22%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $4.11
Upside: +167.64%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $9.33
Upside: +146.52%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $15.07
Upside: +165.43%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $59.35
Upside: +17.94%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $32.91
Upside: +161.32%